Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of GPOEM in the Treatment of Gastroparesis

NCT04349670 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of GPOEM in the Treatment of Gastroparesis
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2020
Completion date
April 1, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis, gastroparesis postoperative, gastroparesis with diabetes mellitus